Movatterモバイル変換


[0]ホーム

URL:


CN104174073A - Method for loading drugs on drug eluting balloon catheter - Google Patents

Method for loading drugs on drug eluting balloon catheter
Download PDF

Info

Publication number
CN104174073A
CN104174073ACN201410426234.2ACN201410426234ACN104174073ACN 104174073 ACN104174073 ACN 104174073ACN 201410426234 ACN201410426234 ACN 201410426234ACN 104174073 ACN104174073 ACN 104174073A
Authority
CN
China
Prior art keywords
medicine
balloon catheter
solvent
eluting balloon
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410426234.2A
Other languages
Chinese (zh)
Other versions
CN104174073B (en
Inventor
董何彦
徐立霞
卢春兰
杜旭东
杨刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIAONING YINYI BIOTECHNOLOGY CO., LTD.
Original Assignee
LIAONING BIOMEDICAL MATERIALS R&D CENTER CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIAONING BIOMEDICAL MATERIALS R&D CENTER CO LtdfiledCriticalLIAONING BIOMEDICAL MATERIALS R&D CENTER CO Ltd
Priority to CN201410426234.2ApriorityCriticalpatent/CN104174073B/en
Publication of CN104174073ApublicationCriticalpatent/CN104174073A/en
Application grantedgrantedCritical
Publication of CN104174073BpublicationCriticalpatent/CN104174073B/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Landscapes

Abstract

The invention relates to a method for loading drugs on a drug eluting balloon catheter. The method comprises the following steps: (1) swelling a balloon for 0.5-3 hours; (2) spraying a mixed liquid composed of therapeutic drugs, additives and a solvent onto the surface of the swelled balloon by adopting a vacuum spraying technology, and naturally drying by air for 10-30 minutes, wherein the weight ratio of the solvent, the therapeutic drugs and the additives in the mixed liquid is (10-90) to (0.5-30) to (5-60); and the solution for swelling the balloon in the step (1) is any one or more of methyl formate, ethyl acetate, ethyl formate, methyl acetate, propyl formate, methyl propionate, ethyl propionate, phenyl acetate, n-octyl acrylate and methyl benzoate. According to the method for loading drugs on the drug eluting balloon catheter, a drug coating can be uniform and firm, and drugs can be released quickly and stably.

Description

A kind of medicine-carrying method of medicine eluting balloon catheter
Technical field
The present invention relates to medical instruments field, especially relate to the medicine-carrying method of a kind of medicine eluting balloon catheter that angioplasty uses.
Background technology
Since Gruntzig in 1977 clinical practice percutaneous tranluminal coronary angioplasty first, Restenosis is the principal focal point of PTCA treatment arguement always.The application of bracket for eluting medicament has effectively solved this problem, becomes the another milestone of percutaneous coronary intervention history.But, the in-stent restenosis that bracket for eluting medicament causes is extremely difficult, if again insert bracket for eluting medicament, the probability of secondary restenosis occurs up to 43%, and the needs of patients of implantation of drug-eluting stent is taken the dual antiplatelet drug of longer time, prevention thrombus in stents; In addition, become, in the special pathological changes such as longer vascular lesion and bifurcated vessels pathological changes at caliber compared with small vessel disease, drug application FirebirdTM patient's therapeutic effect is still undesirable.Under this background, medicine-coated balloon becomes one, field of arteria coronaria intervention and has allure research topic, a new focus.
Medicament elution sacculus is consistent for the preliminary clinical test results of intrastent restenotic lesions: be no matter late period tube chamber loss, restenosis rate or MACE incidence rate, the simple expansion of medicament elution sacculus is all better than using common balloon expandable, and this advantage continues to postoperative 24 months of interventional therapy.Existing multiple medicinal balloons go on the market in Europe, the key of medicinal balloon processing technology is to make medication coat and balloon surface effectively bond and can discharge fast at diseased region, prevent from coming off at folding process and course of conveying floating coat, and can also discharge fast at diseased region.The focus of current research is the medication coat method of Development of Novel.
Publication number is that to adopt the method for laser grinding be that balloon surface is felt irregular nonplanar structure to the Chinese invention patent of CN 101785900A, due to the irregular nonplanar structure of medicinal balloon catheter surface tool, medicine carrying rate is improved, make medicine in course of conveying, be difficult for being washed, can effectively be transported to lesion locations, reach the effect for the treatment of.Publication number provides a kind of drug delivery sacculus for the Chinese invention patent application of CN 102481392A, comprise the coating in surperficial sacculus and at least part of balloon surface, described coating comprises the curative that suppresses cell, excipient and plasticizer, and medicine and the pharmacokinetics of coating in vascular system or target tissue of coating have been described.Publication number is that the Chinese utility model patent of CN 201524344U relates to a kind of novel foley's tube that carries medicament microcapsule.This foley's tube is made up of proximal tube, distal tube, sacculus, medicament microcapsule and flexible tip, and sacculus is the folding sacculus of Memorability, uses special infiltration technology medicament microcapsule to be wrapped in to the fold inner surface of collapsible sacculus.Publication number is that the Chinese invention patent application of CN 102657900A relates to a kind of medicinal balloon and painting method thereof based on hydrogen bond action.This medicinal balloon comprises balloon surface and the medicine layer that contains active medicine, wherein balloon surface is through processing and modifying, make it bring hydrophilic radical, and there is hydrogen bond action between balloon surface and medication coat, pass through hydrogen bond action, increase the cohesive force of medicine layer and balloon surface, ensure the ductility of coating, be beneficial to medicine in balloon surface load.
Above-mentioned medicine carrying mode exists medicine carrying inhomogeneously, insecure easily to come off, be difficult to the problem that discharges fast, in order to improve the performance of medicinal balloon, need to be from balloon surface and medication coat combination seeking breakthrough.
Summary of the invention
The object of this invention is to provide a kind of medicine-carrying method of medicine eluting balloon catheter, the method can make medication coat evenly, firmly, and drug release fast and stable.
The technical solution used in the present invention is:
A medicine-carrying method for medicine eluting balloon catheter, comprises the following steps:
1. first sacculus is carried out to swelling treatment, the time of swelling treatment is 0.5h-3h; 2. adopt airless spraying technology by the balloon surface being sprayed on by the mixed liquor of curative drug, additive and solvent composition after swelling, natural air drying 10-30 minute.
In described mixed liquor, the ratio of weight and number of solvent, curative drug, additive is 10-90:0.5-30:5-60.
1. step carries out sacculus solution that swelling treatment uses is any one in methyl formate, ethyl acetate, Ethyl formate, methyl acetate, propyl formate, methyl propionate, ethyl propionate, phenylacetate, 1-Octyl acrylate and essence of Niobe, or two or more mixing in them.
Step 2. described curative drug is fat-soluble medicine.
Described fat-soluble medicine is any one in the derivant of paclitaxel, rapamycin and two kinds of medicines, or two or more mixing in them.
Step 2. described additive is epoxy resin, acrylic acid, polyurethane, UV glue, alpha-cyanoacrylate, Iopromide, any one in polycarbodiimide, or two or more mixing in them.
Step 2. described solvent is at least one and the mixture of water in ethanol, methanol, acetone, isopropyl alcohol, acetonitrile, ethyl acetate, methyl formate, and the mass concentration of described solvent is 50%-90%.
Advantage and effect that the present invention has are:
The medicine-carrying method of a kind of medicine eluting balloon catheter of the present invention can make medication coat evenly, firmly, and drug release fast and stable.
Utilize normal experiment method, medicament elution sacculus prepared by embodiment of the present invention 1-13 carries out drug release experiment, observes the medicine-releasing performance of medicinal balloon, and result is as table 1:
Table 1:
NumberingDrug release rate (%)
Embodiment 186
Embodiment 279
Embodiment 392
Embodiment 482
Embodiment 584
Embodiment 672
Embodiment 776
Embodiment 882
Embodiment 975
Embodiment 1088
Embodiment 1186
Embodiment 1279
Embodiment 1375
From said medicine release rate data, in embodiment, all medicament elution sacculus release rate in drug release experiment is all higher than 70%, there is good medicine-releasing performance, particularly in embodiment 3, taking ethyl acetate as swelling solution, swelling time is 1 hour, and during taking mass concentration as 60% aqueous acetone solution as spray solution, taking paclitaxel as fat-soluble medicine, taking UV glue as additive, the medicament elution sacculus of preparation drug release rate under these conditions, up to 92%, is significantly better than the medicament elution sacculus of preparing in other embodiment.
Detailed description of the invention
Embodiment 1:
A medicine-carrying method for medicine eluting balloon catheter, comprises the following steps:
1. first sacculus is carried out to swelling treatment: sacculus is placed in to solution submergence 1h, makes it swelling.It is any one in methyl formate, ethyl acetate, Ethyl formate, methyl acetate, propyl formate, methyl propionate, ethyl propionate, phenylacetate, 1-Octyl acrylate and essence of Niobe that sacculus is carried out to solution that swelling treatment uses, or two or more mixing in them.
2. the mixed liquor that preparation contains curative drug, additive, solvent; Swelling sacculus is placed on airless spraying instrument, utilizes airless spraying technology that mixed solution is coated in to balloon surface, natural air drying 10min.Wherein:
In described mixed liquor, the ratio of weight and number of solvent, curative drug, additive is 10-90:0.5-30:5-60.
Described curative drug is any one in the derivant of paclitaxel, rapamycin and two kinds of medicines, or two or more mixing in them.
Described additive is epoxy resin, acrylic acid, polyurethane, UV glue, alpha-cyanoacrylate, Iopromide, any one in polycarbodiimide, or two or more mixing in them.
Described solvent is at least one and the mixture of water in ethanol, methanol, acetone, isopropyl alcohol, acetonitrile, ethyl acetate, methyl formate, and the mass concentration of described solvent is 50%-90%.
The solvent of mixed liquor is methanol aqueous solution in the present embodiment, and fat-soluble medicine is everolimus, and additive is polycarbodiimide, and the mass concentration of methanol aqueous solution is 50%.
The ratio of weight and number of methanol aqueous solution, everolimus, polycarbodiimide is: 10:30:60.
Described in the present embodiment, the sacculus of medicine eluting balloon catheter can be equal diameter, can be also to straighten footpath, irregularly shaped, can be used for coronary artery, also can be used for peripheral blood vessel.The material of described sacculus is polyethylene or nylon or block polyetheramides macromolecular material.
Embodiment 2:
The difference of the present embodiment and embodiment 1 is:
It is methyl acetate that step carries out by sacculus the solution that swelling treatment uses in 1., and swelling Immersion time is 30min.
The step 2. solvent of the mixed liquor of middle preparation is acetonitrile solution, and fat-soluble medicine is rapamycin, and additive is acrylic acid, and the time of natural air drying is 30min.The mass concentration of acetonitrile solution is 90%.
Acetonitrile solution, rapamycin, acrylic acid ratio of weight and number are 90:0.5:5.
Embodiment 3:
The difference of the present embodiment and embodiment 1 is:
It is ethyl acetate that step carries out by sacculus the solution that swelling treatment uses in 1., and swelling Immersion time is 1 hour.
The step 2. solvent of the mixed liquor of middle preparation is aqueous acetone solution, and fat-soluble medicine is paclitaxel, and additive is UV glue, and the time of natural air drying is 25min.The mass concentration of aqueous acetone solution is 60%.
The ratio of weight and number of aqueous acetone solution, paclitaxel, UV glue is 50:15:30.
Embodiment 4:
The difference of the present embodiment and embodiment 1 is:
It is essence of Niobe that step carries out by sacculus the solution that swelling treatment uses in 1., and swelling Immersion time is 3h.
The step 2. solvent of the mixed liquor of middle preparation is isopropanol water solution, and fat-soluble medicine is Docetaxel, and additive is alpha-cyanoacrylate, and the time of natural air drying is 20min.The mass concentration of isopropanol water solution is 70%.
The ratio of weight and number of isopropanol water solution, Docetaxel, alpha-cyanoacrylate is 30:20:40.
Embodiment 5:
The difference of the present embodiment and embodiment 1 is:
It is methyl propionate that step carries out by sacculus the solution that swelling treatment uses in 1., and swelling Immersion time is 2h.
The step 2. mixed liquor solvent of middle preparation is isopropanol water solution, and fat-soluble medicine is albumin paclitaxel, and additive is Iopromide, and the time of natural air drying is 10min.The mass concentration of isopropanol water solution is 80%.
The ratio of weight and number of isopropanol water solution, albumin paclitaxel, Iopromide is 70:10:20.
Embodiment 6:
The difference of the present embodiment and embodiment 1 is:
It is ethyl propionate that step carries out by sacculus the solution that swelling treatment uses in 1., and swelling Immersion time is 1h.
The step 2. solvent of the mixed liquor of middle preparation is ethanol water, and fat-soluble medicine is everolimus, and additive is epoxy resin, and the time of natural air drying is 15min.
Ethanol water, everolimus, weight epoxy portion rate are 10:30:60.
Embodiment 7:
The difference of the present embodiment and embodiment 1 is:
It is 1-Octyl acrylate that step carries out by sacculus the solution that swelling treatment uses in 1., and swelling Immersion time is 2h.
Step is the mixed liquor of middle preparation 2.: solvent is ethanol, methanol, acetone, isopropyl alcohol, acetonitrile, ethyl acetate and methyl formate mixture aqueous solution, in mixture aqueous solution, the ratio of weight and number of ethanol, methanol, acetone, isopropyl alcohol, acetonitrile, ethyl acetate and methyl formate is 1:1:1:1:1:1:1, and the mass concentration of solvent aqueous solution is 90%.Fat-soluble medicine is the mixture of paclitaxel, rapamycin, everolimus, Docetaxel, albumin paclitaxel, in this mixture, the ratio of weight and number of each medicine is 1:1:1:1:1, additive is epoxy resin and acrylic acid mixture, epoxy resin and acrylic acid ratio of weight and number are 1:1, and the time of natural air drying is 20min.
In described mixed liquor, the ratio of weight and number of solvent, fat-soluble medicine, additive is 90:0.5:5.
Embodiment 8:
The difference of the present embodiment and embodiment 1 is:
It is propyl formate that step carries out by sacculus the solution that swelling treatment uses in 1., and swelling Immersion time is 40min.
Step is the mixed liquor of middle preparation 2.: solvent is methyl formate aqueous solution, and the mass concentration of methyl formate aqueous solution is 50%.Fat-soluble medicine is the mixture of rapamycin and paclitaxel, and the ratio of weight and number of rapamycin and paclitaxel is 1:1.Additive is the mixture of UV glue, alpha-cyanoacrylate and Iopromide, and the ratio of weight and number of UV glue, alpha-cyanoacrylate and Iopromide is 1:1:1, and the time of natural air drying is 30min.
In described mixed liquor, the ratio of weight and number of solvent, fat-soluble medicine, additive is 80:20:10.
Embodiment 9:
The difference of the present embodiment and embodiment 1 is:
It is Ethyl formate that step carries out by sacculus the solution that swelling treatment uses in 1., and swelling Immersion time is 1.5h.
The step 2. solvent of the mixed liquor of middle preparation is ethyl acetate aqueous solution, and the mass concentration of ethyl acetate aqueous solution is 60%.Fat-soluble medicine is the mixture of everolimus and albumin paclitaxel, and in this mixture, the ratio of weight and number of each medicine is 1:1, and additive is polyurethane, and the time of natural air drying is 10min.
In described mixed liquor, the ratio of weight and number of solvent, fat-soluble medicine, additive is 60:50:50.
Embodiment 10:
The difference of the present embodiment and embodiment 1 is:
It is ethyl propionate that step carries out by sacculus the solution that swelling treatment uses in 1., and swelling Immersion time is 2.5h.
Step is the mixed liquor of middle preparation 2.: solvent is the mixture aqueous solution of acetonitrile, ethyl acetate and methyl formate, and the ratio of weight and number of acetonitrile, ethyl acetate and methyl formate is 1:1:1, and the mass concentration of solvent aqueous solution is 80%.Fat-soluble medicine is the mixture of paclitaxel, everolimus and rapamycin, in this mixture, the ratio of weight and number of each medicine is 1:1:1, additive is epoxy resin, acrylic acid, polyurethane, UV glue, alpha-cyanoacrylate, the mixture of Iopromide and polycarbodiimide, epoxy resin, acrylic acid, polyurethane, UV glue, alpha-cyanoacrylate, the ratio of weight and number of Iopromide and polycarbodiimide is 1:1:1:1:1:1:1, and the time of natural air drying is 15min.
In described mixed liquor, the ratio of weight and number of solvent, fat-soluble medicine, additive is 10:30:60.
Embodiment 11:
The difference of the present embodiment and embodiment 1 is:
It is the mixed solution of methyl formate, ethyl acetate, Ethyl formate, methyl acetate, propyl formate, methyl propionate, ethyl propionate, phenylacetate, 1-Octyl acrylate and essence of Niobe that step carries out by sacculus the solution that swelling treatment uses in 1., and in mixed solution, the ratio of weight and number of methyl formate, ethyl acetate, Ethyl formate, methyl acetate, propyl formate, methyl propionate, ethyl propionate, phenylacetate, 1-Octyl acrylate and essence of Niobe is 1:1:1:1:1:1:1:1:1:1.Swelling Immersion time is 1h.
Step is the mixed liquor of middle preparation 2.: solvent is the aqueous solution of methanol and acetone mixture, and the ratio of weight and number of methanol and acetone is 1; 1, the mass concentration of solvent aqueous solution is 80%.Fat-soluble medicine is the mixture of rapamycin and everolimus, in this mixture, the ratio of weight and number of each medicine components is 1:1, additive is the mixture of epoxy resin, acrylic acid, polyurethane and UV glue, the ratio of weight and number of epoxy resin, acrylic acid, polyurethane and UV glue is 1:1:1:1, and the time of natural air drying is 10min.
In described mixed liquor, the ratio of weight and number of solvent, fat-soluble medicine, additive is 15:6:60.
Embodiment 12:
The difference of the present embodiment and embodiment 1 is:
It is the mixed solution of propyl formate and methyl propionate that step carries out by sacculus the solution that swelling treatment uses in 1., and in mixed solution, the ratio of weight and number of propyl formate and methyl propionate is 1:1, and swelling Immersion time is 30min.
The step 2. mixed liquor solvent of middle preparation is acetone, isopropanol mixture aqueous solution, and the ratio of weight and number of acetone, isopropyl alcohol is 1:1, and the mass concentration of solvent aqueous solution is 50%.Fat-soluble medicine is the mixture of rapamycin and albumin paclitaxel, and in this mixture, each drug weight portion rate is 1:1, and additive is acrylic acid, and the time of natural air drying is 30min.
In described mixed liquor, the ratio of weight and number of solvent, fat-soluble medicine, additive is 70:25:45.
Embodiment 13: the difference of the present embodiment and embodiment 1 is:
It is the mixed solution of Ethyl formate, methyl acetate, ethyl propionate and phenylacetate that step carries out by sacculus the solution that swelling treatment uses in 1., in mixed solution, the ratio of weight and number of Ethyl formate, methyl acetate, ethyl propionate and phenylacetate is 1:1:1:1, and swelling Immersion time is 30min.
The step 2. mixed liquor solvent of middle preparation is the aqueous solution of isopropyl alcohol, acetonitrile and ethyl acetate mixture, and the ratio of weight and number of isopropyl alcohol, acetonitrile and ethyl acetate is 1:1:1, and the mass concentration of solvent aqueous solution is 80%.Fat-soluble medicine is the mixture of rapamycin, Docetaxel albumin paclitaxel and everolimus, and in this mixture, the ratio of weight and number of each medicine is 1:1:1:1, and additive is acrylic acid mixed liquor, and the time of natural air drying is 30min.
In described mixed liquor, the ratio of weight and number of solvent, fat-soluble medicine, additive is 50:5:12.

Claims (7)

CN201410426234.2A2014-08-272014-08-27A kind of medicine-carrying method of medicine eluting balloon catheterActiveCN104174073B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201410426234.2ACN104174073B (en)2014-08-272014-08-27A kind of medicine-carrying method of medicine eluting balloon catheter

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201410426234.2ACN104174073B (en)2014-08-272014-08-27A kind of medicine-carrying method of medicine eluting balloon catheter

Publications (2)

Publication NumberPublication Date
CN104174073Atrue CN104174073A (en)2014-12-03
CN104174073B CN104174073B (en)2016-07-06

Family

ID=51955599

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201410426234.2AActiveCN104174073B (en)2014-08-272014-08-27A kind of medicine-carrying method of medicine eluting balloon catheter

Country Status (1)

CountryLink
CN (1)CN104174073B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN106237395A (en)*2016-09-302016-12-21鼎科医疗技术(苏州)有限公司A kind of medicine-coated balloon and preparation method thereof
WO2016206078A1 (en)*2015-06-242016-12-29浙江巴泰医疗科技有限公司Method for preparing drug balloon
CN107376028A (en)*2017-07-072017-11-24辽宁垠艺生物科技股份有限公司A kind of medicine for covering air bag plastics pipe surface
CN107519571A (en)*2017-07-272017-12-29上海心至医疗科技有限公司Medicinal balloon and preparation method thereof
CN115397481A (en)*2020-01-202022-11-25英诺拉有限公司Medical products delivering drug enhancing effects

Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN102481392A (en)*2009-06-172012-05-30雅培心血管系统有限公司Drug coated balloon catheter and pharmacokinetic profile
CN102657900A (en)*2012-04-102012-09-12微创医疗器械(上海)有限公司Medicine balloon based on hydrogen bond effects and coating method thereof
CN103536971A (en)*2012-07-122014-01-29赛诺医疗科学技术有限公司Drug eluting medical appliance capable of controllably releasing drugs and preparation method thereof
WO2014125465A2 (en)*2013-02-132014-08-21Prendergast Thomas PatrickMethod for loading dilatable catherer balloons and dilatation catheters obtained therefrom

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN102481392A (en)*2009-06-172012-05-30雅培心血管系统有限公司Drug coated balloon catheter and pharmacokinetic profile
CN102657900A (en)*2012-04-102012-09-12微创医疗器械(上海)有限公司Medicine balloon based on hydrogen bond effects and coating method thereof
CN103536971A (en)*2012-07-122014-01-29赛诺医疗科学技术有限公司Drug eluting medical appliance capable of controllably releasing drugs and preparation method thereof
WO2014125465A2 (en)*2013-02-132014-08-21Prendergast Thomas PatrickMethod for loading dilatable catherer balloons and dilatation catheters obtained therefrom

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
董何彦等: ""新型无聚合物微盲孔载药支架的研究"", 《辽宁师范大学学报(自然科学版)》*

Cited By (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2016206078A1 (en)*2015-06-242016-12-29浙江巴泰医疗科技有限公司Method for preparing drug balloon
CN106237395A (en)*2016-09-302016-12-21鼎科医疗技术(苏州)有限公司A kind of medicine-coated balloon and preparation method thereof
CN106237395B (en)*2016-09-302019-09-20鼎科医疗技术(苏州)有限公司A kind of medicine-coated balloon and preparation method thereof
CN107376028A (en)*2017-07-072017-11-24辽宁垠艺生物科技股份有限公司A kind of medicine for covering air bag plastics pipe surface
CN107519571A (en)*2017-07-272017-12-29上海心至医疗科技有限公司Medicinal balloon and preparation method thereof
CN115397481A (en)*2020-01-202022-11-25英诺拉有限公司Medical products delivering drug enhancing effects

Also Published As

Publication numberPublication date
CN104174073B (en)2016-07-06

Similar Documents

PublicationPublication DateTitle
US11752313B2 (en)Balloon catheter including a drug delivery sheath
US10058636B2 (en)Drug coated balloon catheter
US9724497B2 (en)Method of coating a catheter balloon having a fold
CN102958544B (en)Improved coating formulations for scoring or cutting balloon catheters
CN103948975B (en)A kind of targeted drug release gets involved class medical apparatus and instruments and preparation method thereof
CN104174073B (en)A kind of medicine-carrying method of medicine eluting balloon catheter
CN109985280B (en)Drug balloon and preparation method thereof
CN106237395B (en)A kind of medicine-coated balloon and preparation method thereof
CN205041957U (en)Medicine sacculus and medicine sacculus pipe
CN107376030B (en)Preparation method of drug balloon, prepared drug balloon and application thereof
CN220778756U (en)Medical device and system
EP2335745B1 (en)Implant with coating
CN106178138A (en)A kind of medicinal balloon
CN204246659U (en)A kind of medicament slow release foley's tube
WO2018059207A1 (en)New use of amlexanox
CN107995869B (en)Surface liquefied drug coating sacculus
US9907935B2 (en)Coating of balloon catheters
CN201543095U (en)Medicine-coated balloon
Roy-Chaudhury et al.Novel therapies for hemodialysis vascular access dysfunction: fact or fiction!
US20170368235A1 (en)Pharmaceutical compositions and device methods for treatment of proliferative diseases
EP3213721A1 (en)Drug-eluting stent
CN115337523B (en)Medicine saccule and its preparation method
CN107823724A (en)A kind of intravascular stent with medication coat
CN120132189A (en) Drug-eluting balloon catheter system
US20210346658A1 (en)Active-substance coating for balloons of balloon catheters

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
C14Grant of patent or utility model
GR01Patent grant
C56Change in the name or address of the patentee
CP01Change in the name or title of a patent holder

Address after:Guangming Street Jinzhou District of Dalian City, Liaoning Province, Han Road No. 8-11 116100

Patentee after:LIAONING YINYI BIOTECHNOLOGY CO., LTD.

Address before:Guangming Street Jinzhou District of Dalian City, Liaoning Province, Han Road No. 8-11 116100

Patentee before:Liaoning Biomedical Materials R&D Center Co., Ltd.


[8]ページ先頭

©2009-2025 Movatter.jp